Simrat Randhawa serves as Executive at Dianthus Therapeutics, Inc. /DE/, where they oversee executive responsibilities. Since joining the company, Simrat Randhawa has executed 12 insider transactions totaling $7.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 3, 2026 involved receiving (via award) 150,000 shares valued at $0.
Simrat Randhawa currently holds 150,000 shares of Dianthus Therapeutics, Inc. /DE/ (DNTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Simrat Randhawa has been a net seller of DNTH stock. They have purchased $52.8K and sold $7.4M worth of shares.
Simrat Randhawa's most recent insider trade was on Feb 3, 2026, when they sold 150,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $38.14 |
| Discretionary |
| Nov 14, 2025 | DNTH | $689.7K | Option Exercise | 31,250 | $22.07 | Discretionary |
| Nov 14, 2025 | DNTH | $816.2K | Option Exercise | 37,494 | $21.77 | Discretionary |
| Nov 14, 2025 | DNTH | $720.3K | Option Exercise | 40,287 | $17.88 | Discretionary |
| Nov 13, 2025 | DNTH | $63.1K | Option Exercise | 3,529 | $17.88 | Discretionary |
| Nov 13, 2025 | DNTH | $708.8K | Option Exercise | 83,978 | $8.44 | Discretionary |
| Nov 13, 2025 | DNTH | $936.7K | Sale | 26,166 | $35.80 | Discretionary |
| Nov 13, 2025 | DNTH | $1.6M | Sale | 42,765 | $37.04 | Discretionary |
| Nov 13, 2025 | DNTH | $700.7K | Sale | 18,576 | $37.72 | Discretionary |
| Sep 22, 2023 | DNTH | $26.4K | Purchase | 2,000 | $13.20 | Discretionary |
| Sep 21, 2023 | DNTH | $26.4K | Purchase | 2,000 | $13.20 | Discretionary |